Gene · 93
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics network analyses of growth differentiation factor 11. | Open Life Sci | 2022 | 35582621 | PubTator, text mining | PubMed |
| Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant. | Thorax | 2022 | 35580897 | PubTator, text mining | PubMed |
| Clinical Developmental Cardiology for Understanding Etiology of Congenital Heart Disease. | J Clin Med | 2022 | 35566507 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Current Treatment Options for Cancer Cachexia. | Cancers (Basel) | 2022 | 35565236 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in the Human Placenta. | Cells | 2022 | 35563893 | PubTator, text mining | PubMed |
| An Antisense Oligonucleotide against a Splicing Enhancer Sequence within Exon 1 of the MSTN Gene Inhibits Pre-mRNA Maturation to Act as a Novel Myostatin Inhibitor. | Int J Mol Sci | 2022 | 35563408 | PubTator, text mining | PubMed |
| The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications. | Front Immunol | 2022 | 35558080 | PubTator, text mining | PubMed |
| Spectrum of Genetic Variants in a Cohort of 37 Laterality Defect Cases. | Front Genet | 2022 | 35547246 | PubTator, text mining | PubMed |
| Recent progress in drug development for fibrodysplasia ossificans progressiva. | Mol Cell Biochem | 2022 | 35536530 | PubTator, text mining | PubMed |
| The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses. | Comput Intell Neurosci | 2022 | 35528328 | PubTator, text mining | PubMed |
| Single Cell RNA-Seq Analysis of Human Red Cells. | Front Physiol | 2022 | 35514346 | PubTator, text mining | PubMed |
| Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1. | J Clin Invest | 2022 | 35511419 | PubTator, text mining | PubMed |
| Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin. | J Cachexia Sarcopenia Muscle | 2022 | 35510530 | PubTator, text mining | PubMed |
| Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10. | Nat Commun | 2022 | 35504921 | PubTator, text mining | PubMed |
| Sex-specific extracellular matrix remodeling during early adipogenic differentiation by gestational bisphenol A exposure. | Chemosphere | 2022 | 35504463 | PubTator, text mining | PubMed |
| Research Progress of Exosomes in Bone Diseases: Mechanism, Diagnosis and Therapy. | Front Bioeng Biotechnol | 2022 | 35497358 | PubTator, text mining | PubMed |
| RNA sequence analysis identified bone morphogenetic protein-2 (BMP2) as a biomarker underlying form deprivation myopia. | Biochem Biophys Rep | 2022 | 35494490 | PubTator, text mining | PubMed |
| Identifying pleiotropic variants and candidate genes for fertility and reproduction traits in Holstein cattle via association studies based on imputed whole-genome sequence genotypes. | BMC Genomics | 2022 | 35484513 | PubTator, text mining | PubMed |
| Progress in the Study of Non-Coding RNAs in Multidifferentiation Potential of Dental-Derived Mesenchymal Stem Cells. | Front Genet | 2022 | 35480302 | PubTator, text mining | PubMed |
| Pan-cancer analysis of microRNA expression profiles highlights microRNAs enriched in normal body cells as effective suppressors of multiple tumor types: A study based on TCGA database. | PLoS One | 2022 | 35476804 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/93/papers?page=17